Stage 2 Cervical Cancer Treatment in Ahmedabad — Dr. Nishtha Tripathi Patel is an ESGO-certified gynaecological oncosurgeon offering specialist treatment for stage 2 cervical cancer treatment at Sterling Hospitals, KD Hospital and Welcare Speciality Hospital in Ahmedabad.
On this page
- What this stage means
- Recommended treatment pathway
- Adjuvant therapy
- Outlook and survival data
- Booking
- FAQs
What does this stage mean?
Stage 2 cervical cancer extends beyond the cervix but not to the pelvic side wall. Stage 2A (upper vagina involvement): radical hysterectomy may be considered for selected cases, otherwise chemoradiation. Stage 2B (parametrial involvement): primary chemoradiation is standard. Brachytherapy is essential and must be image-guided.
For broader information see our cancer overview and treatment page.
Recommended treatment pathway
Stage 2 cervical cancer extends beyond the cervix but not to the pelvic side wall. Stage 2A (upper vagina involvement): radical hysterectomy may be considered for selected cases, otherwise chemoradiation. Stage 2B (parametrial involvement): primary chemoradiation is standard. Brachytherapy is essential and must be image-guided.
Adjuvant therapy
Concurrent cisplatin-based chemoradiation followed by image-guided brachytherapy is the standard. Surgical option only for highly selected Stage 2A.
Outlook
5-year survival approximately 65-75% with optimal chemoradiation; up to 80% in carefully selected surgical candidates.
External authoritative reference: NCCN Guidelines and ESGO Recommendations.
Booking
For an individualised treatment plan, share your reports on WhatsApp (+91 76988 00333) or book an appointment. Second opinions are available for patients already under care elsewhere.
FAQs
Where is stage 2 cervical cancer treatment performed in Ahmedabad?
Dr. Nishtha Tripathi Patel treats this disease stage at Sterling Hospitals (Sindhubhavan), KD Hospital, and Welcare Speciality Hospital in Ahmedabad. The hospital is chosen based on the specific procedure needed and patient preference.
What is the typical hospital stay?
For minimally invasive surgery (robotic or laparoscopic), hospital stay is typically 3-4 days. For cytoreductive surgery or HIPEC, stay extends to 7-10 days. Chemoradiation is outpatient over 5-7 weeks.
What is the likely outcome?
5-year survival approximately 65-75% with optimal chemoradiation; up to 80% in carefully selected surgical candidates. Outcomes are stage-dependent and individual; the figures above are averages from published series.
Is fertility preservation possible?
Fertility preservation is not standard for this stage. Egg or embryo cryopreservation may be considered before chemotherapy if applicable.
Can I get a second opinion before deciding?
Yes. Share your reports on WhatsApp (+91 76988 00333). Dr. Nishtha provides independent review of stage, pathology, imaging and proposed treatment within 24-48 hours.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified.